JPS5913510B2 - Calbostyril Yudou Tainoseizohou - Google Patents
Calbostyril Yudou TainoseizohouInfo
- Publication number
- JPS5913510B2 JPS5913510B2 JP50157140A JP15714075A JPS5913510B2 JP S5913510 B2 JPS5913510 B2 JP S5913510B2 JP 50157140 A JP50157140 A JP 50157140A JP 15714075 A JP15714075 A JP 15714075A JP S5913510 B2 JPS5913510 B2 JP S5913510B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- formula
- alkyl group
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
■0 本発明は新規なカルボスチリル誘導体の製造法に
関する。DETAILED DESCRIPTION OF THE INVENTION (1) The present invention relates to a novel method for producing carbostyril derivatives.
本発明で得られるカルボスチリル誘導体は、一般式〔式
中R1は水素原子、炭素数1〜4のアルキル基又はアル
キル部分の炭素数が1〜4であるアルアルキル基を、R
2は水素原子又は炭素数1〜3のアルキル基を、Aは側
鎖に炭素数1〜3のアルキル基を有し若しくは有しない
炭素数1〜4のアルキレン基、ベンゼン環に直結する酸
素原子を有し且つ側鎖に炭素数1〜3のアルキル基を有
し若*}(しくは有しない炭素数1〜4のアルキレンオ
キシ基をそれぞれ示す。The carbostyryl derivative obtained in the present invention has the following general formula:
2 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, A is an alkylene group having 1 to 4 carbon atoms with or without an alkyl group having 1 to 3 carbon atoms in the side chain, and an oxygen atom directly connected to the benzene ring. and an alkyleneoxy group having 1 to 4 carbon atoms and having or not having an alkyl group having 1 to 3 carbon atoms in the side chain.
Bはフエニル基、p−メチルフエニル基又はp−メトキ
シフエニル基を、3・4位の点線は飽和若しくは二重結
合をそれぞれ示す。〕で表わされる5−〔(2一置換ア
ミノ−1ヒドロキシ)アルキル]カルボスチリル誘導体
である。本発明で得られる化合物はいずれも新規化合物
であり、β−アドレナリン作動神経刺激作用、抗痙窒作
用、降圧作用、脱コレステロール作用、消炎作用、冠拡
張作用、抗アレルギ一作用、抗パーキンソン氏病作用、
利尿作用、抗ビールス作用、β−アドレナリン作働神経
遮断作用等を有し医薬品として重要である。B represents a phenyl group, p-methylphenyl group or p-methoxyphenyl group, and the dotted lines at the 3rd and 4th positions represent saturated or double bonds, respectively. ] is a 5-[(2-monosubstituted amino-1hydroxy)alkyl]carbostyryl derivative. The compounds obtained in the present invention are all new compounds, and have β-adrenergic nerve stimulating action, antispasmodic action, antihypertensive action, decholesterol action, antiinflammatory action, coronary dilation action, antiallergic action, and antiparkinsonian action. action,
It is important as a medicine because it has diuretic, antiviral, and β-adrenergic nerve blocking effects.
式〔I]の化合物で代表的なものを第1表に示す。Representative compounds of formula [I] are shown in Table 1.
式〔〕で表わされる5−〔(2一置換アミノ1−ヒドロ
キシ)アルキル〕カルボスチリル誘導体は、一般式〔式
中R1、R2、A.B及び3・4位の点線は上記に同じ
。The 5-[(2-monosubstituted amino-1-hydroxy)alkyl]carbostyryl derivative represented by the formula [] has the general formula [where R1, R2, A. The dotted lines for B and 3rd and 4th place are the same as above.
〕で表わされる5−(α一置換アミノアルカノイル)カ
ルボスチリル誘導体を還元することにより製造される。It is produced by reducing a 5-(α-monosubstituted aminoalkanoyl)carbostyryl derivative represented by ].
還元方法としては従米公知のものを広く使用でき、その
具体例としては例えばナトリウムボロンヒドリド、リチ
ウムアルミニウムヒドリド等の水素化剤を用いる方法、
パラジウム、パラジウム黒、白金、ラネーニツケル等の
金属触媒の存在下で接触還元する方法等を例示できる。As the reduction method, a wide range of known methods can be used, and specific examples thereof include methods using hydrogenating agents such as sodium boron hydride and lithium aluminum hydride;
Examples include a method of catalytic reduction in the presence of a metal catalyst such as palladium, palladium black, platinum, or Raney nickel.
水素化剤を用いる場合には式〔〕の化合物に対して通常
0.5〜5倍モル程度、金属触媒を用いる場合には式〔
〕の化合物に対して通常0.1〜0.5重量程度用いら
れる。When using a hydrogenating agent, it is usually about 0.5 to 5 times the mole of the compound of formula [], and when using a metal catalyst, it is usually about 0.5 to 5 times the mole of the compound of formula [].
] is usually used in an amount of about 0.1 to 0.5 weight per weight of the compound.
金属触媒を用いる場合には1〜10気圧程度の水素圧下
で還元を行なうのがよい。上記還元反応は水素化剤を用
いる場合には水、メタノール、エタノール、酢酸、テト
ラヒドロフラン等の適当な溶媒中で、金属触媒を用いる
場合には水、メタノール、エタノール等の溶媒中で通常
氷水冷下〜溶媒の沸点の温度範囲で約0.5〜13時間
程度で容易に進行し、式〔1〕で表わされる5−〔(2
一置換アミノ−1−ヒドロキシ)アルキル〕カルボスチ
リル誘導体が製造される。When a metal catalyst is used, the reduction is preferably carried out under hydrogen pressure of about 1 to 10 atmospheres. The above reduction reaction is carried out in an appropriate solvent such as water, methanol, ethanol, acetic acid, or tetrahydrofuran when using a hydrogenating agent, or in a solvent such as water, methanol, or ethanol when using a metal catalyst, usually under cooling with ice water. ~ It progresses easily in about 0.5 to 13 hours in the temperature range of the boiling point of the solvent, and 5-[(2
A monosubstituted amino-1-hydroxy)alkyl]carbostyryl derivative is produced.
上記において出発原料として用いる一般式〔〕で表わさ
れる5−(α一置換アミノアルカノイル)カルボスチリ
ル誘導体は、新規化合物であり、一般式〔式中R1、R
2及び3・4位の点線は上記に同じ、Xはハロゲン原子
を示す。The 5-(α-monosubstituted aminoalkanoyl)carbostyryl derivative represented by the general formula [ ] used as a starting material in the above is a new compound,
The dotted lines at the 2nd, 3rd and 4th positions are the same as above, and X represents a halogen atom.
〕で表わされる5一(α−ハロアルカノイル)カルボス
チリル誘導体と、一般式H2N−A−B 〔〕
〔式中A及びBは上記に同じ〕で表わされるアミンとを
脱ハロゲン化水素縮合反応させることにより製造される
。5-(α-haloalkanoyl)carbostyryl derivative represented by ] and an amine represented by the general formula H2N-A-B [ ] [where A and B are the same as above] are subjected to a dehydrohalogenation condensation reaction Manufactured by
上記一般式〔〕の化合物の製造のための出発原料の1つ
である式〔〕の化合物も新規化合物であり、例えば一般
式〔式中R1及び3・4位の点線は上記に同じ〕で表わ
される公知のカルボスチリル誘導体と一般式〔式中R2
及びXは上記に同じ、X″はXと同一又は相異なつてハ
ロゲン原子を示す。The compound of the formula [], which is one of the starting materials for the production of the compound of the general formula [] above, is also a new compound. Known carbostyril derivatives represented by the general formula [wherein R2
and X are the same as above, and X'' is the same or different from X and represents a halogen atom.
〕で表わされるα−ハロアルカン酸ハライドとを、塩化
アルミニウム等のフリーデルークラフツ触媒の存在下、
二硫化炭素、ニトロベンゼン等の溶媒中で−10℃〜溶
媒の沸点の温度範囲で反応させることにより製造される
。また上記一般式〔〕の化合物の製造のための他の1つ
の出発原料である式〔〕の化合物としては公知のものを
広く使用でき、例えばアニリン、p−メトキシアニリン
、アンフエタミン、p−メトキシアンフエタミン、1−
メチル−2−フエノキシエチルアミン、3′・4′−メ
チレンジオキシアンフエタミン、p−メトキシフエネチ
ルアミン、1−メチル−3−フエニルプロピルアミン、
pメチルアンフエタミン等を例示できる。] in the presence of a Friedel-Crafts catalyst such as aluminum chloride,
It is produced by reacting in a solvent such as carbon disulfide or nitrobenzene at a temperature ranging from -10°C to the boiling point of the solvent. Further, as the compound of formula [] which is another starting material for the production of the compound of the above general formula [], a wide range of known compounds can be used, such as aniline, p-methoxyaniline, amphetamine, p-methoxyaniline, etc. Fetamine, 1-
Methyl-2-phenoxyethylamine, 3',4'-methylenedioxyamphetamine, p-methoxyphenethylamine, 1-methyl-3-phenylpropylamine,
Examples include p-methylamphetamine.
上記一般式〔〕の化合物の製造のための縮合反応は、一
般には式〔]のアミンを過剰に用いて無溶媒中或は水、
メタノール、エタノール、イソプロパノール、アセトニ
トリル等の適当な溶媒中で行なわれる。The condensation reaction for producing the compound of the above general formula [] is generally carried out using an excess of the amine of the formula [] in the absence of a solvent or in water,
It is carried out in a suitable solvent such as methanol, ethanol, isopropanol, acetonitrile, etc.
該縮合反応の反応温度は通常室温〜溶媒の沸点の範囲程
度でよく、通常0.5〜10時間で反応は容易に進行し
、式〔〕で表わされる5−(α一置換アミノアルカノイ
ル)カルボスチリル誘導体が製造される。上述のように
して得られた式〔〕の化合物及び本発明に係る式〔1〕
の化合物は▲過、洗浄、再結晶等の公知の手段によつて
分離、精製することができる。The reaction temperature of the condensation reaction is usually in the range of room temperature to the boiling point of the solvent, and the reaction usually proceeds easily in 0.5 to 10 hours, and the reaction temperature is usually within the range of room temperature to the boiling point of the solvent. A styryl derivative is produced. Compound of formula [] obtained as described above and formula [1] according to the present invention
The compound can be separated and purified by known means such as filtration, washing, and recrystallization.
本発明化合物はいずれもアミン誘導体であり水に不溶の
場合が多いが、生理的に許容される塩酸塩、硫酸塩、マ
レイン酸塩、クエン酸塩等の酸付加塩とする等医薬品と
して必要な水溶性を持たせることができる。以下に参考
例及び実施例を掲げて本発明を説明する。All of the compounds of the present invention are amine derivatives and are often insoluble in water, but they can be used as pharmaceutically acceptable acid addition salts such as physiologically acceptable hydrochlorides, sulfates, maleates, and citrates. It can be made water soluble. The present invention will be described below with reference to reference examples and examples.
参考例 1
8−メトキシカルボスチリル10y1ニトロベンゼン1
5m1及びα−プロモブチリルブロマイド30f7を混
和し、氷冷下無水塩化アルミニウム32Vを徐々に加え
た後55〜60℃で4時間攪拌する。Reference example 1 8-methoxycarbostyryl 10y1 nitrobenzene 1
5ml and α-promobutyryl bromide 30f7 were mixed, and anhydrous aluminum chloride 32V was gradually added under ice cooling, followed by stirring at 55 to 60°C for 4 hours.
反応液を氷水200m1に注入し、生成する析出物を沢
取次いでエタノール洗浄後メタノールより再結晶して融
点169〜170℃の5−(α−プロモブチリル)−8
−メトキシカルボスチリル11.5yを得る。参考例
2
8−メトキシカルボスチリルJモV、クロロアセチルクロ
ライド9y及びニトロベンゼン10m1を混和し、氷冷
下無水塩化アルミニウム217を徐徐に加えた後60〜
65℃で4時間撹拌する。The reaction solution was poured into 200 ml of ice water, the precipitate formed was collected, washed with ethanol, and recrystallized from methanol to give 5-(α-promobutyryl)-8 with a melting point of 169-170°C.
-Methoxycarbostyril 11.5y is obtained. Reference example
2. Mix 8-methoxycarbostyryl JMoV, chloroacetyl chloride 9y, and 10 ml of nitrobenzene, and slowly add 217 ml of anhydrous aluminum chloride under ice-cooling.
Stir at 65°C for 4 hours.
反応液を氷水500m1に注入し、生成する析出物を沢
取次いでエタノールで洗浄後メタノールより再結晶して
融点243〜244℃の5−クロロアセチル−8−メト
キシカルボスチリル8.5f7を得る。参考例 35−
(α−ブロモプロピオニル)−8−メトキシ−3・4−
ジヒドロカルボスチリル5yに(2p−メトキシフエニ
ルエチル)アミン20yを加えて室温で6時間攪拌後、
石油エーテルで過剰のアミンを抽出、除去し更に析出物
をエーテルで洗浄後メタノールを加えて溶解した。The reaction solution was poured into 500 ml of ice water, the precipitate formed was collected, washed with ethanol, and then recrystallized from methanol to obtain 5-chloroacetyl-8-methoxycarbostyryl 8.5f7 having a melting point of 243-244°C. Reference example 35-
(α-bromopropionyl)-8-methoxy-3,4-
After adding 20y of (2p-methoxyphenylethyl)amine to 5y of dihydrocarbostyryl and stirring at room temperature for 6 hours,
Excess amine was extracted and removed with petroleum ether, the precipitate was washed with ether, and methanol was added to dissolve it.
メタノール層に47%臭酸を加えてPH+1として不溶
物を沢去し、濃縮、乾固した。残留物をメタノールエー
テルより再結晶して白色結晶の5−〔α(2−p−メト
キシフエニルエチル)アミノプロピオニル〕−8−メト
キシ−3・4−ジヒドロカルボスチリル臭化水素塩3.
6yを得た。M.p.l98〜20「C(分解)
参考例 4及び5
参考例3と同様に操作して下記化合物を得た。47% hydrochloric acid was added to the methanol layer to adjust the pH to +1 to remove insoluble materials, and the mixture was concentrated and dried. The residue was recrystallized from methanol ether to give white crystals of 5-[α(2-p-methoxyphenylethyl)aminopropionyl]-8-methoxy-3,4-dihydrocarbostyryl hydrobromide.3.
I got 6y. M. p. 198-20 "C (Decomposition) Reference Examples 4 and 5 The following compound was obtained by operating in the same manner as in Reference Example 3.
参考例 45−〔(1−メチル−2−p−メトキシフエ
ニルエチル)アミノブチリル〕−8−ヒドロキシカルボ
スチリル臭化水素塩1水和物M.p.28l〜283℃
(分解)、白色結晶参考例 58−ベンジルオキシ一5
−〔(1−メチル−2フエノキシエチル)アミノアセチ
ル〕カルボスチリル塩酸塩M.p.2l7〜220℃、
白色結晶
実施例 1
8−ベンジルオキシ−5−〔(1−メチル−2フエノキ
シエチル)アミノアセチル〕カルボスチリル塩酸塩2V
にメタノール50m1を加え、氷水冷攪拌下苛性カリ−
メタノール溶液を加えて弱アルカリ性とし、ナトリウム
ボロンヒドリド1.27を少量ずつ加え更に室温で1時
間攪拌した。Reference Example 45-[(1-Methyl-2-p-methoxyphenylethyl)aminobutyryl]-8-hydroxycarbostyryl hydrobromide monohydrate M. p. 28l~283℃
(decomposition), white crystal reference example 58-benzyloxy-5
-[(1-Methyl-2phenoxyethyl)aminoacetyl]carbostyril hydrochloride M. p. 2l7~220℃,
White crystal Example 1 8-benzyloxy-5-[(1-methyl-2phenoxyethyl)aminoacetyl]carbostyril hydrochloride 2V
Add 50 ml of methanol to the solution and add caustic potash under stirring under ice water cooling.
A methanol solution was added to make the mixture slightly alkaline, and 1.27 g of sodium boron hydride was added little by little, followed by further stirring at room temperature for 1 hour.
反応液に濃塩酸を加えてPHキ1として析出物を沢去し
、次いで沢液を濃縮、乾固し、更にメタノールを加えて
濃縮乾固した。残留物にアセトンを加えて結晶化、沢取
し、少量の濃塩酸で洗浄後、エタノール−エーテルより
再結晶して白色結晶の8−ベンジルオキシ−5−〔(1
−ヒドロキシ−2−(1−メチル−2−フエノキシエチ
ル)アミノ)エチル〕カルボスチリル塩酸塩1水和物1
.47を得た。M.p.l92〜19『C(分解)
実施例 2
5−〔α一(2−p−メトキシフエニルエチル)アミノ
プロピオニル〕−8−メトキシ−3・4ジヒドロカルボ
スチリル臭化水素塩1.5f7にパラジウム黒0.47
及び水100m1を加え水素圧5気圧、60℃で12時
間接触還元したのち触媒を沢去し、沢液を濃縮、乾固し
た。Concentrated hydrochloric acid was added to the reaction solution to make the pH level 1, and the precipitate was removed.The solution was then concentrated to dryness, and methanol was added thereto and concentrated to dryness. The residue was crystallized by adding acetone, collected, washed with a small amount of concentrated hydrochloric acid, and recrystallized from ethanol-ether to give white crystals of 8-benzyloxy-5-[(1
-Hydroxy-2-(1-methyl-2-phenoxyethyl)amino)ethyl]carbostyril hydrochloride monohydrate 1
.. I got 47. M. p. 192-19 "C (decomposition) Example 2 5-[α-(2-p-methoxyphenylethyl)aminopropionyl]-8-methoxy-3,4 dihydrocarbostyryl hydrobromide 1.5f7 with palladium black 0.47
After adding 100 ml of water and carrying out catalytic reduction under a hydrogen pressure of 5 atm at 60° C. for 12 hours, the catalyst was removed and the solution was concentrated and dried.
残留物を水より再結晶して白色結晶の5−〔(1−ヒド
ロキシ−2(2−p−メトキシフエニルエチル)アミノ
)プロピル〕−8−メトキシ−3・4−ジヒドロカルボ
スチリル臭化水素塩%水和物1.27を得た。M.p.
l73〜175%C(分解)実施例 3及び4
実施例1と同様に操作して下記化合物を得た。The residue was recrystallized from water to give white crystals of 5-[(1-hydroxy-2(2-p-methoxyphenylethyl)amino)propyl]-8-methoxy-3,4-dihydrocarbostyryl hydrogen bromide. A salt % hydrate of 1.27 was obtained. M. p.
173-175% C (decomposition) Examples 3 and 4 The following compound was obtained by operating in the same manner as in Example 1.
Claims (1)
はアルキル部分の炭素数が1〜4であるアルアルキル基
を、R^2は水素原子又は炭素数1〜3のアルキル基を
、Aは側鎖に炭素数1〜3のアルキル基を有し若しくは
有しない炭素数1〜4のアルキレン基、ベンゼン環に直
結する酸素原子を有し且つ側鎖に炭素数1〜3のアルキ
ル基を有し若しくは有しない炭素数1〜4のアルキレン
オキシ基をそれぞれ示す。 Bはフェニル基、p−メチルフェニル基又はp−メトキ
シフェニル基を、3・4位の点線は飽和若しくは二重結
合をそれぞれ示す。〕で表わされる5−(α−置換アミ
ノアルカノイル)カルボスチリル誘導体を還元すること
を特徴とする、一般式▲数式、化学式、表等があります
▼ 〔式中R^1、R^2、A、B及び3・4位の点線は上
記に同じ。 〕で表わされる5−〔(2−置換アミノ−1−ヒドロキ
シ)アルキル〕カルボスチリル誘導体の製造法。[Claims] 1 General formula ▲ Numerical formula, chemical formula, table, etc. an alkyl group, R^2 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, A is an alkylene group having 1 to 4 carbon atoms with or without an alkyl group having 1 to 3 carbon atoms in the side chain, benzene Each represents an alkyleneoxy group having 1 to 4 carbon atoms which has an oxygen atom directly connected to the ring and has or does not have an alkyl group having 1 to 3 carbon atoms in the side chain. B represents a phenyl group, p-methylphenyl group or p-methoxyphenyl group, and the dotted lines at the 3rd and 4th positions represent saturated or double bonds, respectively. ] There are general formulas ▲ mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, R^1, R^2, A, The dotted lines for B and 3rd and 4th place are the same as above. ] A method for producing a 5-[(2-substituted amino-1-hydroxy)alkyl]carbostyryl derivative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50157140A JPS5913510B2 (en) | 1975-12-26 | 1975-12-26 | Calbostyril Yudou Tainoseizohou |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50157140A JPS5913510B2 (en) | 1975-12-26 | 1975-12-26 | Calbostyril Yudou Tainoseizohou |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5283379A JPS5283379A (en) | 1977-07-12 |
JPS5913510B2 true JPS5913510B2 (en) | 1984-03-30 |
Family
ID=15643057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50157140A Expired JPS5913510B2 (en) | 1975-12-26 | 1975-12-26 | Calbostyril Yudou Tainoseizohou |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5913510B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0453380Y2 (en) * | 1985-05-28 | 1992-12-15 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57154129A (en) * | 1981-03-16 | 1982-09-22 | Otsuka Pharmaceut Co Ltd | Cardiotonic drug |
GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
WO2003042160A1 (en) | 2001-11-13 | 2003-05-22 | Theravance, Inc. | Aryl aniline beta-2 adrenergic receptor agonists |
US20030229058A1 (en) | 2001-11-13 | 2003-12-11 | Moran Edmund J. | Aryl aniline beta2 adrenergic receptor agonists |
TWI249515B (en) | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
TW200526547A (en) | 2003-09-22 | 2005-08-16 | Theravance Inc | Amino-substituted ethylamino β2 adrenergic receptor agonists |
TW200531692A (en) | 2004-01-12 | 2005-10-01 | Theravance Inc | Aryl aniline derivatives as β2 adrenergic receptor agonists |
WO2005121065A2 (en) | 2004-06-03 | 2005-12-22 | Theravance, Inc. | DIAMINE β2 ADRENERGIC RECEPTOR AGONISTS |
JP2008512470A (en) | 2004-09-10 | 2008-04-24 | セラヴァンス, インコーポレーテッド | Amidine-substituted arylaniline compounds |
-
1975
- 1975-12-26 JP JP50157140A patent/JPS5913510B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0453380Y2 (en) * | 1985-05-28 | 1992-12-15 |
Also Published As
Publication number | Publication date |
---|---|
JPS5283379A (en) | 1977-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4358455A (en) | Aralkylamindethanol heterocyclic compounds | |
JPS60231681A (en) | Ma nufacture of chroman derivative | |
JPS5922697B2 (en) | Bis-(meta-amidinophenoxy)-compound | |
JPS5913510B2 (en) | Calbostyril Yudou Tainoseizohou | |
EP0179855B1 (en) | Dopamine agonists | |
JPS596861B2 (en) | Method for producing 5-[(2-halogeno-1-hydroxy)alkyl[carbostyryl derivative] | |
US4091115A (en) | 7-Amino-benzocycloheptenes | |
JPS6113471B2 (en) | ||
US3118884A (en) | Derivatives of 3-azaphenothiazine and 3-azaphenoxazine | |
US3808335A (en) | (2-imidazolin-2-ylamino)substituted benzo(b)thiophenes for treating hypertension | |
US4714702A (en) | Quinazolinone derivative | |
JPH03120271A (en) | Phenyl alkylamine derivative having anti-ischemic activity | |
US4021558A (en) | 1,3-Dioxo-2-[(methoxyphenethyl-amino)-alkyl]-4,4-dimethyl-isoquinolines and salts thereof useful as hypotensive agents | |
JPS6010031B2 (en) | Method for producing carbostyril derivatives | |
US3093652A (en) | Alkyl 1-(2-aryl-2-oxoalkyl)-4-phenylpiperidine-4-carboxylates and their preparation | |
Schenker et al. | Iodinated 5-and 8-Hydroxyisoquinolines as Potential Amebicides | |
US3192228A (en) | N-(aminoalkyl)-endo-perhydro-4, 7-methanoisoindoles | |
JPS6053016B2 (en) | Novel 3,4-dihydrocarbostyryl derivative | |
US3882130A (en) | 4-Phenylethynyl benzylamines | |
JPS6010033B2 (en) | Method for producing carbostyril derivatives | |
KR800000537B1 (en) | Process for the preparation of amin-pheny-etahnolamines | |
US3786154A (en) | Compositions and method employing 1-(4-hydroxy-3'-(hydroxymethyl)-phenyl)1-hydroxy-2-aralkylaminoethanes | |
US2882296A (en) | 2-diethylaminoethyl 3-amino-2-alkyoxybenzoates and their preparation | |
JPS5936620B2 (en) | Method for producing 5-(α-haloalkanoyl)carbostyryl derivative | |
JPS6026780B2 (en) | 1-(4-isopropylthiophenyl)-2-aminopropane derivative and method for producing the same |